THE SHARE: Change: +0.00 SEK (+1.87%) / Price: 0.22 SEK / Jan 23, 2025, 6:00 pm (CET)

Home
About
Technology
Portfolio
Investor Relations
Media
Contact
- Contact us

24 May, 2023

CEO interview – Submission of application to start Tumorad® clinical phase I/IIa study

About Spago Nanomedical

Spago Nanomedical AB is a Swedish nanomedicines company in clinical development phase. The company´s development projects are based on a platform of polymeric materials with unique properties for more precise diagnosis and treatment of life-threatening and debilitating diseases.

Address

Spago Nanomedical AB
Scheelevägen 22
SE-223 63 Lund
Sweden

Contact

Phone: +46 46 811 88
LinkedIn